Posted on September 30, 20259/30/25
Strategic PICO Planning: Enhancing Early-Phase Development for Market Access
Posted on February 28, 20252/28/25
Successfully Navigating the Complexity of Market Access Across Europe to Improve Health Equity
Posted on February 27, 20252/27/25
Securing Launch Success Within the Context of the New EU Health Technology Assessment Regulation (HTAR) Landscape in Europe
Posted on October 2, 202410/2/24
AI, Digital Therapeutics Transformation & Cross-Industry Collaboration – What’s On Tap at Frontiers Health
Posted on September 27, 20249/27/24
Digital Therapeutics: A Necessity for Italy – Insights from Roberto Ascione and Alberta Spreafico
Posted on September 23, 20249/23/24
Launching in the EU/U.K.: The 7-Step Countdown to Success
Posted on September 13, 20249/13/24
Understanding Key Reforms for High-Cost Drugs in EU4+UK Markets
Posted on August 21, 20248/21/24
EVERSANA Experts On-Stage at Frontiers Health 2024
Posted on August 7, 20248/7/24
Clinical Data Portability for Regulatory Submissions Across Global Markets
Posted on August 2, 20248/2/24